Medical complications of substance abuse

References

• Howland J, Hingson R. Alcohol as a risk factor for injuries or death due to fires and burns: review of the literature. Public Health Rep 1987: 102(5): 475–83
   PubMed Web of Science ®Google Scholar
• Patetta MJ, Biddinger PW. Characteristics of drowning deaths in North Carolina. Public Health Rep 1988: 103(4): 406–11
   PubMed Web of Science ®Google Scholar
• Haverkos HW, Genser SG, Grace WC, et al. Complications of drug misuse. Curr Opin Psychiatr 1991: 4: 454–9
   Google Scholar
• Blumenthal RS, Flaherty JT. Recognizing cardiac crises in cocaine abusers: acute care for ischemia, MI, cardiomyopathy—often in young patients. J Crit Illness 1990: 5(3): 225–39
   Google Scholar
• Isncr JM, Chokshi SK. Cocaine and vasospasm. (Editorial) N Engl J Med 1989: 321(23): 1604–6
   PubMed Web of Science ®Google Scholar
• Nademanee K, Gorelick DA, Josephson MA, et al Myocardial ischemia during cocaine withdrawal. Ann Intern Med 1989: 111(11): 876–80
   PubMed Web of Science ®Google Scholar
• Wiener RS, Lockhart JT, Schwartz RG. Dilated cardiomyopathy and cocaine abuse: report of two cases. Am J Med 1986: 81 (4): 699–701
   PubMed Web of Science ®Google Scholar
• Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 1991: 265(9): 1152–4
   PubMed Web of Science ®Google Scholar
• Levine DR. Infectious endocarditis in intravenous drug abusers. In: Levine DP, Sobel JD, eds. Infections in intravenous drug abusers. New York: Oxford Univ Press, 1991: 251–85
   Google Scholar
• Schnoll SH. Aiding the drug abuser. Hosp Med 1983: (Aug): 116–55
   Google Scholar
• Margolis MT, Newton TH. Methamphetamine (“speed”) arteritis. Neuroradiology 1971: 2(3): 179–82
   PubMed Web of Science ®Google Scholar
• Mames RN, Spoor TC. Ocular manifestations of intravenous drug abuse. In: Levine, Sobel, eds,9 pp 167–82
   Google Scholar
• Kaku DA, Lowenstein DH. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 1990: 113(11): 821–7
   PubMed Web of Science ®Google Scholar
• Cherubin CE. Epidemiology of tetanus in narcotic addicts. NY State J Med 1970: 70(2): 267–71
   PubMedGoogle Scholar
• Wilford BB. Clinical complications of drug abuse. In: Drug abuse: a guide for the primary care physician. Chicago: American Medical Assn, 1981: 177–202
   Google Scholar
• Levinson A, Marske RL, Shein MK. Tetanus in heroin addicts. JAMA 1955: 157(8): 658–60
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Street-drug contaminant causing parkinsonism. MMWR 1984: 33(24): 351–2
   PubMedGoogle Scholar
• Landrigan PJ, Powell KE, James LM, et al. Paraquat and marijuana: epidemiologic risk assessment. Am J Public Health 1983: 73(7): 784–8
   PubMed Web of Science ®Google Scholar
• Scheidegger C, Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis 1989: 11(3): 486–93 [erratum, Rev Infect Dis 1990: 12(1): 165]
   PubMedGoogle Scholar
• Haverkos HW, Lange WR. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990: 161 (May): 894–902 [erratum, J Infect Dis 1990: 162(6): 1421]
   PubMedGoogle Scholar
• Donald P. Advanced malignancy in the young marijuana smoker. In: Friedman H, Specter S, Klein TW, eds. Advances in experimental medicine and biology. Vol 288. Drugs of abuse, immunity, and immunodeficiency. New York: Plenum Press, 1991: 33–46
   Google Scholar
• Mutchnick MG, Lee HH, Neman RR. Liver disease associated with intravenous drug abuse. In: Levine, Sobel, eds,9 pp 286–305
   Google Scholar
• Lange WR, Moore JD, Kreider SD. The prevalence of serological markers to hepatitis A and hepatitis B in drug abuse personnel. Am J Prev Med 1986: 2(2): 109–15
   PubMedGoogle Scholar
• Donahue JG, Nelson KE, Mufioz A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991: 134(10): 1206–11
   PubMed Web of Science ®Google Scholar
• Alezander M. Indicators of drug abuse: hepatitis. NIDA Res Monogr 1977: (10): 123–9
   Google Scholar
• Klein TW, Newton C, Friedman H. Inhibition of natural killer cell function by marijuana components. J Toxicol Environ Health 1987: 20(4): 321–32
   PubMed Web of Science ®Google Scholar
• Goedert JJ. Recreational drugs: relationship to AIDS. Ann NY Acad Sci 1984: 437: 192–9
   PubMed Web of Science ®Google Scholar
• Novick DM, Ochshom M, Kreek MJ. In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts. In: Friedman et al, eds, 21 pp 159–70
   Google Scholar
• Nelson S, Bagby G, Andrcsen J, et al. The effects of ethanol, tumor necrosis factor, and granulocyte colony-stimulating factor on lung antibacterial defenses. In: Friedman et al, eds,21 pp 245–54
   Google Scholar
• Kolodny RC, Masters WH, Kolodner RM, et al. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974: 290(16): 872–4
   PubMed Web of Science ®Google Scholar
• Falek A, Hollingsworth F. Opiates and human chromosome alterations. Int J Addict 1980: 15(2): 155–63
   PubMed Web of Science ®Google Scholar
• Butterfield CR, Shockley M, San Miguel G, et al. Routine screening for hepatitis B in an obstetric population. Obstet Gynecol 1990: 76(1): 25–7
   PubMed Web of Science ®Google Scholar
• Martin JN Jr, Martin RW, Hess LW, et al. Pregnancy-associated substance abuse and addiction: current concepts and management. J Miss State Med Assoc 1988: 29(12): 369–74
   PubMedGoogle Scholar
• Chasnoff IJ. Perinatal effects of cocaine. Contemp Ob/Gyn 1987: (May): 163–79
   Google Scholar
• Zweben JE, Payte JT. Methadone maintenance in the treatment of opioid dependence: a current perspective. West J Med 1990: 152(5): 588–99
   PubMedGoogle Scholar